VACCINEX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.41 USD | -10.63% |
|
+28.20% | -31.13% |
| May. 16 | Earnings Flash (VCNX) VACCINEX Reports Q1 Revenue $104,000 | MT |
| Apr. 12 | Vaccinex, Inc. announced that it has received $1.75 million in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VACCINEX, INC. | Bio Therapeutic Drugs | -10.63% | +28.20% | -31.13% | -92.78% | -99.47% | 11.36M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- VCNX Stock
- Charts Vaccinex, Inc.
- Comparison Chart
